Welcome to LookChem.com Sign In|Join Free
  • or
DL-Isoleucine Methyl Ester Hydrochloride is a chemical compound with the molecular formula C7H15NO2·HCl. It is a derivative of the amino acid isoleucine, where the carboxyl group is esterified with a methyl group and the compound is protonated with hydrochloric acid. This results in a zwitterionic structure, with a positively charged ammonium group and a negatively charged carboxyl group. DL-Isoleucine Methyl Ester Hydrochloride is used in various applications, including pharmaceuticals, as a building block for peptide synthesis, and in research studies. It is an essential component in the synthesis of certain drugs and can also be used as a flavoring agent in the food industry.

5619-06-7

Post Buying Request

5619-06-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5619-06-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5619-06-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,6,1 and 9 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 5619-06:
(6*5)+(5*6)+(4*1)+(3*9)+(2*0)+(1*6)=97
97 % 10 = 7
So 5619-06-7 is a valid CAS Registry Number.

5619-06-7Relevant academic research and scientific papers

Ligand-Enabled γ-C(sp3)–H Acetoxylation of Triflyl-Protected Amines

Jia, Wen-Liang,Fernández-Ibá?ez, M. ángeles

supporting information, p. 6088 - 6091 (2018/09/14)

A palladium-catalyzed γ-C(sp3)–H acetoxylation of triflyl-protected amines has been achieved. The use of pyridine or 2-alkoxyquinoline-type ligands is key to the success of this transformation. The reaction is highly diastereoselective and easily scalable, and constitutes a direct approach for the synthesis of γ-hydroxy-α-amino acids and β,γ-dihydroxy amines, which are not readily accessible by other routes.

NOVEL HDAC INHIBITORS AND METHODS OF TREATMENT USING THE SAME

-

Paragraph 000189, (2017/03/21)

Disclosed herein are novel HDAC inhibitors. The HDAC inhibitors may be used in methods of treating cancer. The HDAC inhibitors may be used in methods of treating a neurological disorder.

Highly tunable arylated cinchona alkaloids as bifunctional catalysts

Quigley, Cormac,Rodriguez-Docampo, Zaida,Connon, Stephen J.

supporting information; scheme or table, p. 1443 - 1445 (2012/03/11)

We report the design and evaluation of a library of chiral bifunctional organocatalysts in which the distance between the catalytically active units can be systematically varied.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5619-06-7